Aspira Womens Health Inc (AWH)
3.15
-0.90 -22.22%
NASDAQ
Aug 14, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 4.955M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.17 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -15.23M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 34.43% |
| Profit Margin (Quarterly) | -303.8% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 326.58M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 58.48 |
| PE Ratio | -- |
| Price to Book Value | 61.59 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.2346 |
| Free Cash Flow (Quarterly) | -3.524M |
| Return on Equity | Upgrade |
View All AWH News
News
-
WireHeadlineTime (ET)
-
Globe Newswire08/14 15:51
-
Globe Newswire08/13 16:01
-
Globe Newswire07/31 09:23
-
Yahoo07/08 06:30
-
MT Newswires07/01 13:56
-
SA Breaking News07/01 11:38
-
Globe Newswire07/01 11:23
-
MT Newswires06/29 08:29
-
Globe Newswire06/29 08:00
-
MT Newswires06/11 11:25
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/12/2020 16:30 EST | Misc | Vermillion Inc Third Quarter Earnings Conference Call for 2020 |
| 11/12/2020 | Earnings | Vermillion Inc Third Quarter Earnings for 2020 Release |
| 08/13/2020 16:30 EDT | Misc | Aspira Womens Health Inc Second Quarter Earnings Conference Call for 2020 |
| 08/13/2020 | Earnings | Aspira Womens Health Inc Second Quarter Earnings Result for 2020 |
| 06/23/2020 08:00 EDT | Misc | Vermillion Inc Annual General Meeting for 2019 |
| 05/14/2020 16:30 EDT | Misc | Vermillion Inc First Quarter Earnings Conference Call for 2020 |
| 05/14/2020 | Earnings | Vermillion Inc First Quarter Earnings Result for 2020 |
| 04/07/2020 | Misc | Vermillion Inc Annual Report for 2019 |
| 03/26/2020 16:30 EDT | Misc | Vermillion Inc Fourth Quarter Earnings Conference Call for 2019 |
| 03/26/2020 | Earnings | Vermillion Inc Fourth Quarter Earnings for 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.aspirawh.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121814&p=irol-IRHome
- HQ State/Province: Texas
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Blend
- Next Earnings Release: Nov. 12, 2020
- Last Earnings Release: Aug. 13, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.15 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- AWH Tweets Stocktwits
Advertisement
